Has Paul Haun, MD received payments from drug or device companies?

Yes. Drug and device makers reported $85,329 in general payments to Paul Haun, MD across 138 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Paul Haun, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Paul Haun, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Paul Haun, MD

Dermatology · Portland, ORNPI 1881980738

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $66,400 of the $85,329 with a category attached, or 77.8%. Kyowa Kirin, Inc. accounts for 97.5% of it on its own, with 18 other manufacturers making up the rest. 2025 is the largest year on record at $50,223, 8.0 times the $6,273 reported in 2019. Among dermatology clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$85,329in general payments, 2019–2025

Across 138 payments — averaging $618.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Kyowa Kirin, Inc.$83K
AbbVie$735
Sanofi$289
Pfizer$193
Johnson & Johnson$192
E.r. Squibb & Sons, L.L.C.$148
plus $601 from 13 others

What the payments were for

Consulting fees$11,75514%
Speaking & faculty fees$66,40078%
Travel & lodging$4,1445%
Food & beverage$3,0294%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Kyowa Kirin, Inc.	50	$83,170
AbbVie	30	$735
Sanofi	7	$289
Pfizer	10	$193
Johnson & Johnson	9	$192
E.r. Squibb & Sons, L.L.C.	2	$148
Amgen	5	$109
Helsinn Therapeutics (U.S.), Inc.	5	$102
Lilly USA, LLC	4	$89
Mayne Pharma Commercial LLC	4	$52
LEO Pharma Inc.	2	$50
Verrica Pharmaceuticals Inc.	2	$50
Arcutis Biotherapeutics, Inc.	2	$32
Regeneron Healthcare Solutions, Inc.	1	$27
Medline Industries LP	1	$20
Almirall LLC	1	$20
UCB, Inc.	1	$18
Novartis	1	$18
Sun Pharmaceutical Industries Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

POTELIGEO$82,357
SANCUSO$6,200
Sotyktu$125
Rinvoq$121

How this compares

$85,329 in reported general payments places this provider in the 95th percentile of 175 dermatology providers in Oregon.

See all dermatology providers in Oregon →

Medicare billing

Part B allowed, 2024

$127,676

Medicare patients

777

Services billed

2,290

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent PenDupilumab	29	$107,873
Tacrolimus	17	$3,037
Clobetasol Propionate	58	$2,212
Ketoconazole	131	$2,087
Desonide	12	$1,914
Triamcinolone Acetonide	108	$1,685
Betamethasone Dipropionate	30	$1,419
Clindamycin Phosphate	40	$1,003
Metronidazole	14	$996
Doxycycline Hyclate	53	$906
Ciclopirox	11	$124
Finasteride	18	$123
Mupirocin	17	$81
Hydrocortisone	15	$72
Prednisone	18	$63

Paid to pharmacies, not to this prescriber.

Other dermatology in Portland

Andrew BlauveltPortland$1.8M
Benjamin EhstPortland$1.5M
Jason HawkesPortland$1.5M
Eric SimpsonPortland$1.4M
Alex Ortega LoayzaPortland$122K
Omar QutubPortland$107K
Kathryn SchwarzenbergerPortland$34K
Jon HanifinPortland$25K
Phoebe RichPortland$17K
Tracy FunkPortland$16K

See the full list for Oregon →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →